Cargando…
Methanolic Extract of Rhizoma Coptidis Inhibits the Early Viral Entry Steps of Hepatitis C Virus Infection
Hepatitis C Virus (HCV) remains an important public health threat with approximately 170 million carriers worldwide who are at risk of developing hepatitis C-associated end-stage liver diseases. Despite improvement of HCV treatment using the novel direct-acting antivirals (DAAs) targeting viral repl...
Autores principales: | Hung, Ting-Chun, Jassey, Alagie, Lin, Chien-Ju, Liu, Ching-Hsuan, Lin, Chun-Ching, Yen, Ming-Hong, Lin, Liang-Tzung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6315547/ https://www.ncbi.nlm.nih.gov/pubmed/30486350 http://dx.doi.org/10.3390/v10120669 |
Ejemplares similares
-
(4R,6S)-2-Dihydromenisdaurilide is a Butenolide that Efficiently Inhibits Hepatitis C Virus Entry
por: Chung, Chueh-Yao, et al.
Publicado: (2016) -
Identification of the phytobioactive Polygonum cuspidatum as an antiviral source for restricting dengue virus entry
por: Kuo, Yu-Ting, et al.
Publicado: (2020) -
Hepatitis C Virus Non-Structural Protein 5A (NS5A) Disrupts Mitochondrial Dynamics and Induces Mitophagy
por: Jassey, Alagie, et al.
Publicado: (2019) -
A Compositive Strategy to Study the Pharmacokinetics of TCMs: Taking Coptidis Rhizoma, and Coptidis Rhizoma-Glycyrrhizae Radix et Rhizoma as Examples
por: Li, Qiao, et al.
Publicado: (2018) -
Antiviral Activities of Silymarin and Derivatives
por: Liu, Ching-Hsuan, et al.
Publicado: (2019)